Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing.

Cohen K, Tzika A, Wood H, Berri S, Roberts P, Mason G, Sheridan E.

Ultrasound Obstet Gynecol. 2015 Apr;45(4):394-401. doi: 10.1002/uog.14767.

PMID:
25510919
2.

Next-generation sequencing analysis for detecting human papillomavirus in oral verrucous carcinoma.

Samman M, Wood H, Conway C, Berri S, Pentenero M, Gandolfo S, Cassenti A, Cassoni P, Al Ajlan A, Barrett AW, Chengot P, MacLennan K, High AS, Rabbitts P.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jul;118(1):117-125.e1. doi: 10.1016/j.oooo.2014.03.018. Epub 2014 Apr 12.

3.

Estimating optimal window size for analysis of low-coverage next-generation sequence data.

Gusnanto A, Taylor CC, Nafisah I, Wood HM, Rabbitts P, Berri S.

Bioinformatics. 2014 Jul 1;30(13):1823-9. doi: 10.1093/bioinformatics/btu123. Epub 2014 Mar 5.

PMID:
24603986
4.

An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing.

Stead LF, Egan P, Devery A, Conway C, Daly C, Berri S, Wood H, Belvedere O, Papagiannopoulos K, Ryan A, Rabbitts P.

PLoS One. 2013 Nov 11;8(11):e78823. doi: 10.1371/journal.pone.0078823. eCollection 2013.

5.

Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone.

Appleby BS, Lu M, Bizzi A, Phillips MD, Berri SM, Harbison MD, Schonberger LB.

Emerg Infect Dis. 2013 Apr;19(4):682-4. doi: 10.3201/eid1904.121504. No abstract available.

6.

Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation.

Hayes JL, Tzika A, Thygesen H, Berri S, Wood HM, Hewitt S, Pendlebury M, Coates A, Willoughby L, Watson CM, Rabbitts P, Roberts P, Taylor GR.

Genomics. 2013 Sep;102(3):174-81. doi: 10.1016/j.ygeno.2013.04.006. Epub 2013 Apr 15.

7.

The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma.

Stead LF, Berri S, Wood HM, Egan P, Conway C, Daly C, Papagiannopoulos K, Rabbitts P.

Neoplasia. 2012 Nov;14(11):1075-86.

8.

A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease.

Hamlin C, Puoti G, Berri S, Sting E, Harris C, Cohen M, Spear C, Bizzi A, Debanne SM, Rowland DY.

Neurology. 2012 Aug 7;79(6):547-52. doi: 10.1212/WNL.0b013e318263565f. Epub 2012 Jul 25.

9.

Gait Modulation in C. elegans: An Integrated Neuromechanical Model.

Boyle JH, Berri S, Cohen N.

Front Comput Neurosci. 2012 Mar 7;6:10. doi: 10.3389/fncom.2012.00010. eCollection 2012.

10.

Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors.

Conway C, Chalkley R, High A, Maclennan K, Berri S, Chengot P, Alsop M, Egan P, Morgan J, Taylor GR, Chester J, Sen M, Rabbitts P, Wood HM.

J Mol Diagn. 2012 Mar-Apr;14(2):104-11. doi: 10.1016/j.jmoldx.2011.10.003. Epub 2012 Jan 10.

11.

A computational index derived from whole-genome copy number analysis is a novel tool for prognosis in early stage lung squamous cell carcinoma.

Belvedere O, Berri S, Chalkley R, Conway C, Barbone F, Pisa F, MacLennan K, Daly C, Alsop M, Morgan J, Menis J, Tcherveniakov P, Papagiannopoulos K, Rabbitts P, Wood HM.

Genomics. 2012 Jan;99(1):18-24. doi: 10.1016/j.ygeno.2011.10.006. Epub 2011 Oct 25.

12.

Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data.

Gusnanto A, Wood HM, Pawitan Y, Rabbitts P, Berri S.

Bioinformatics. 2012 Jan 1;28(1):40-7. doi: 10.1093/bioinformatics/btr593. Epub 2011 Oct 28.

13.

Gait Modulation in C. Elegans: It's Not a Choice, It's a Reflex!

Boyle JH, Berri S, Tassieri M, Hope IA, Cohen N.

Front Behav Neurosci. 2011 Mar 7;5:10. doi: 10.3389/fnbeh.2011.00010. eCollection 2011. No abstract available.

14.

Characterization of WRKY co-regulatory networks in rice and Arabidopsis.

Berri S, Abbruscato P, Faivre-Rampant O, Brasileiro AC, Fumasoni I, Satoh K, Kikuchi S, Mizzi L, Morandini P, Pè ME, Piffanelli P.

BMC Plant Biol. 2009 Sep 22;9:120. doi: 10.1186/1471-2229-9-120.

15.

Forward locomotion of the nematode C. elegans is achieved through modulation of a single gait.

Berri S, Boyle JH, Tassieri M, Hope IA, Cohen N.

HFSP J. 2009 Jun;3(3):186-93. doi: 10.2976/1.3082260. Epub 2009 Mar 26.

16.

Combination treatment for acute ischemic stroke: A ray of Hope?

Fagan SC, Bowes MP, Berri SA, Zivin JA.

J Stroke Cerebrovasc Dis. 1999 Nov-Dec;8(6):359-67.

PMID:
17895189
17.

Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.

McLaughlin P, Narayana V, Pan C, Berri S, Troyer S, Herman J, Evans V, Roberson P.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):144-50. Epub 2005 Oct 21.

PMID:
16243441
18.

EU-OSTID: a collection of transposon insertional mutants for functional genomics in rice.

van Enckevort LJ, Droc G, Piffanelli P, Greco R, Gagneur C, Weber C, González VM, Cabot P, Fornara F, Berri S, Miro B, Lan P, Rafel M, Capell T, Puigdomènech P, Ouwerkerk PB, Meijer AH, Pe' E, Colombo L, Christou P, Guiderdoni E, Pereira A.

Plant Mol Biol. 2005 Sep;59(1):99-110.

PMID:
16217605
19.

Functional anatomy of the prostate: implications for treatment planning.

McLaughlin PW, Troyer S, Berri S, Narayana V, Meirowitz A, Roberson PL, Montie J.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):479-91.

PMID:
16168840
20.

Development of an HPLC method for the identification and dosage of non-allowed substances in cosmetic products. Part I: local anaesthetics and antihistaminics.

Porrà R, Berri S, Gagliardi L, Chimenti P, Granese A, De Orsi D, Carpani I, Tonelli D.

Anal Bioanal Chem. 2004 Nov;380(5-6):767-72.

PMID:
15517209
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk